Injectable procedures are the most common aestethical oprations playing part in everyday aestethical medical practice. The techniques have improved over the years but unexpected consequences may follow after any surgical or injectable ivasive aeastethical operation, regardless its a small or a complex. Any operation has a potential of creating uncomfortable side effects, like bruising, swelling, discomfort and sometimes even infections around the operation site.
Bruising is caused by extravasation of red blood cells into the tissue if the a blood vessel is breached during the procedure and may occur even after small aestethical operations where surgical or injectable procederes are being used. This may cause aestethical harm to patients for several days or even weeks after operation.
Widgerow et al (2020) used the Delfin SkinColorCatch in a study to test topical formulas to enhance bruise healing and to reduce the severity of bruising. They tested a compound utilizing peptides and active agents showed significant results in reduction of bruise color intensity. The participants using this specifically produced compound had a statistically significant improvement in bruise color intensity over the use of bland moisturizer after two days into the intervention. And overall, 81 % of the participants had less bruising over the control group after two days.
”The Delfin SkinColorCatch was deemed the most accurate means of assessment”.
-Widgerow et al. (2020)
The Delfin SkinColorCatch is all-in-one colorimetry for assessments of skin color, eythema and melanin indices. The Delfin SkinColorCatch is also suitable for many other aestethical study applications e.g. pigmentation, skin-whitening, skin-aging or scars.
Delfin Technologies Ltd
info@delfintech.com
References:
Widgerow, A. D. et al. (2020) ‘Developing a topical adjunct to injectable procedures’, Journal of Drugs in Dermatology, 19(4), pp. 398–404.
Conclusion
A Platform for Precision, Portability and Progress
TDC measurement is no longer just a research tool — it’s a clinically valuable, field-proven solution for objective edema assessment. With Delfin’s LymphScanner, healthcare providers gain access to real-time, actionable data that improves diagnostics, enhances therapy monitoring, and supports evidence-based care.
At the same time, medical researchers are leveraging the same technology to explore new frontiers in skin and soft tissue science — including breast edema, lower limb lymphedema, head and neck swelling, and midline edema.
Whether you're treating lymphedema or designing the next clinical study, Delfin's TDC devices empower you with precision you can trust — in the palm of your hand.
